Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML.
Majdic
O
O
Institute of Immunology, University of Vienna, Austria.
Sugita
K
K
Touw
I
I
Köller
U
U
Stockinger
H
H
Delwel
R
R
Löwenberg
B
B
Knapp
W
W
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001853:Bone Marrow / Q000276:immunology; D016026:Bone Marrow Transplantation; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy*; D014411:Neoplastic Stem Cells / Q000276:immunology; D014182:Transplantation, Autologous
D000911:Antibodies, Monoclonal; D003165:Complement System Proteins